ANN ARBOR, MI, Oct., 9–(HSMN NewsFeed)) - Lycera Corp., which is developing novel small-molecule pharmaceuticals to treat autoimmune diseases, today announced the appointments of Paul S. Changelian, Ph.D. and Peter L. Toogood, Ph.D. to the company’s drug …
Biopharmaceuticals, Personnel
Lycera

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Lycera Appoints Key Executives to Drug Development Team”
Leave a Comment